ATE331218T1 - Verwendung von blauen kupferproteinen - Google Patents

Verwendung von blauen kupferproteinen

Info

Publication number
ATE331218T1
ATE331218T1 AT00956443T AT00956443T ATE331218T1 AT E331218 T1 ATE331218 T1 AT E331218T1 AT 00956443 T AT00956443 T AT 00956443T AT 00956443 T AT00956443 T AT 00956443T AT E331218 T1 ATE331218 T1 AT E331218T1
Authority
AT
Austria
Prior art keywords
protein
apo
metal binding
cell
binding protein
Prior art date
Application number
AT00956443T
Other languages
English (en)
Inventor
Inge Dierynck
Christiaan Hubert Simo Roelant
Rudi Wilfried Jan Pauwels
Acker Koenraad Lodewijk Au Van
Kerpel Jan Octaaf Antoon De
Original Assignee
Tibotec Bvba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Bvba filed Critical Tibotec Bvba
Application granted granted Critical
Publication of ATE331218T1 publication Critical patent/ATE331218T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/581—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/583—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with non-fluorescent dye label

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00956443T 1999-08-06 2000-08-04 Verwendung von blauen kupferproteinen ATE331218T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14733999P 1999-08-06 1999-08-06

Publications (1)

Publication Number Publication Date
ATE331218T1 true ATE331218T1 (de) 2006-07-15

Family

ID=22521174

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00956443T ATE331218T1 (de) 1999-08-06 2000-08-04 Verwendung von blauen kupferproteinen

Country Status (7)

Country Link
EP (1) EP1282813B1 (de)
AT (1) ATE331218T1 (de)
AU (1) AU6838400A (de)
DE (1) DE60029017T2 (de)
ES (1) ES2267556T3 (de)
TW (1) TWI286601B (de)
WO (1) WO2001011358A2 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210019A (en) * 1990-03-30 1993-05-11 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Pseudomonas screening assay
ZA967411B (en) * 1995-09-01 1997-04-16 Novo Nordisk Biotech Inc Blue copper oxidase mutants with enhanced activity

Also Published As

Publication number Publication date
DE60029017T2 (de) 2007-06-28
EP1282813A2 (de) 2003-02-12
WO2001011358A3 (en) 2002-11-14
TWI286601B (en) 2007-09-11
DE60029017D1 (de) 2006-08-03
ES2267556T3 (es) 2007-03-16
WO2001011358A2 (en) 2001-02-15
EP1282813B1 (de) 2006-06-21
AU6838400A (en) 2001-03-05

Similar Documents

Publication Publication Date Title
ATE470150T1 (de) Methode zum schnellen identifizieren von kleinen organischen liganden
BR9709015A (pt) Quinolina carboxamidas como inbidores de tnf e como inbidores de pde-iv
MY154826A (en) Fusion protein capable of binding vegf
DE60126592D1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
ATE451390T1 (de) Polypeptide zur bindung an das b-lymphozyten- stimulatorische protein (blys)
BR0213786A (pt) Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
DE69632466D1 (de) Lösung die chaotropische mittel enthält und verwendung dieser lösung in verfahren zur isolierung von dna, rna und proteinen
BR0016569A (pt) Processo de isolamento de rna de espécimes de tecido embutidos - parafina fixados - formalina
DE69838544D1 (de) Isolierung von gewebspezifischen peptidliganden und ihre verwendung zur ausrichtung von pharmazeutika auf zielorgane
BR0209990A (pt) Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
WO2002093129A3 (en) Methods for analyzing interactions between proteins in live and intact cells
ES2168361T3 (es) Secuencias de adn para metaloproteasas de la matriz, su preparacion y empleo.
ATE428928T1 (de) Verfahren zur einführung von heterologischen zellen in fische
WO2005000335A3 (en) Use of genes differentially expressed during aging of liver for treatment and diagnosis
DE69714775D1 (de) Verfahren zur Tötung von Zielzellen in geernteten Zellpopulationen mit Hilfe von zwei Immunotoxinen
DE60132443D1 (de) In lebenden zielzellen
ATE331218T1 (de) Verwendung von blauen kupferproteinen
WO2005017102A3 (en) Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins
EA200301207A1 (ru) Новые экспрессирующие векторы и их применение
WO2004053075A3 (en) Compositions, splice variants and methods relating to breast specific genes and proteins
WO2007020522A3 (en) Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type
WO2003106648A3 (en) COMPOSITIONS AND METHODS RELATED TO BREAST SPECIFIC GENES AND PROTEINS
WO2003066877A3 (en) Compositions and methods relating to hepatic specific genes and proteins
WO2004052290A3 (en) Compositions, splice variants and methods relating to breast specific genes and proteins
WO2003020899A3 (en) Compositions and methods relating to lung specific genes and proteins

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1282813

Country of ref document: EP